FY2022 EPS Estimates for R1 RCM Inc. Boosted by Analyst (NASDAQ:RCM)

R1 RCM Inc. (NASDAQ:RCMGet Rating) – Stock analysts at SVB Leerink boosted their FY2022 earnings per share (EPS) estimates for R1 RCM in a research report issued to clients and investors on Monday, April 11th. SVB Leerink analyst S. Davis now forecasts that the healthcare provider will earn $0.43 per share for the year, up from their prior forecast of $0.40. SVB Leerink also issued estimates for R1 RCM’s FY2023 earnings at $0.61 EPS.

A number of other equities research analysts also recently weighed in on the company. Guggenheim initiated coverage on R1 RCM in a research report on Wednesday. They set a “neutral” rating on the stock. Deutsche Bank Aktiengesellschaft initiated coverage on R1 RCM in a research report on Wednesday, February 9th. They set a “buy” rating and a $30.00 price objective on the stock. Robert W. Baird raised their price objective on R1 RCM from $29.00 to $32.00 in a research report on Thursday, March 3rd. Finally, Zacks Investment Research raised R1 RCM from a “sell” rating to a “hold” rating in a research report on Wednesday, February 16th. Two research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, R1 RCM has a consensus rating of “Buy” and a consensus target price of $29.13.

RCM opened at $27.46 on Tuesday. R1 RCM has a 12-month low of $18.71 and a 12-month high of $27.95. The company has a current ratio of 1.43, a quick ratio of 1.43 and a debt-to-equity ratio of 2.19. The business’s fifty day simple moving average is $25.85 and its 200-day simple moving average is $24.32. The company has a market capitalization of $7.64 billion, a price-to-earnings ratio of -12.77, a PEG ratio of 3.15 and a beta of 0.77.

R1 RCM (NASDAQ:RCMGet Rating) last posted its quarterly earnings results on Thursday, February 17th. The healthcare provider reported $0.11 EPS for the quarter, topping the Zacks’ consensus estimate of $0.10 by $0.01. R1 RCM had a return on equity of 30.22% and a net margin of 6.59%. The company had revenue of $398.90 million for the quarter, compared to analysts’ expectations of $399.26 million. During the same period in the previous year, the firm earned $0.06 EPS. The firm’s revenue was up 21.5% compared to the same quarter last year.

A number of hedge funds have recently made changes to their positions in RCM. BlackRock Inc. raised its holdings in R1 RCM by 2.6% during the fourth quarter. BlackRock Inc. now owns 18,439,516 shares of the healthcare provider’s stock worth $470,024,000 after purchasing an additional 465,555 shares in the last quarter. American Century Companies Inc. boosted its position in shares of R1 RCM by 4.8% in the 4th quarter. American Century Companies Inc. now owns 3,797,569 shares of the healthcare provider’s stock worth $96,800,000 after buying an additional 174,530 shares in the last quarter. Eaton Vance Management boosted its position in shares of R1 RCM by 7.4% in the 4th quarter. Eaton Vance Management now owns 3,480,336 shares of the healthcare provider’s stock worth $88,706,000 after buying an additional 239,147 shares in the last quarter. Wellington Management Group LLP raised its stake in R1 RCM by 23.4% in the 3rd quarter. Wellington Management Group LLP now owns 3,138,521 shares of the healthcare provider’s stock valued at $69,079,000 after purchasing an additional 596,012 shares during the last quarter. Finally, Sunriver Management LLC raised its stake in R1 RCM by 58.7% in the 3rd quarter. Sunriver Management LLC now owns 2,319,322 shares of the healthcare provider’s stock valued at $51,048,000 after purchasing an additional 857,490 shares during the last quarter. 41.53% of the stock is owned by institutional investors.

About R1 RCM (Get Rating)

R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. The company offers end-to-end RCM services to manage their revenue cycle operations that encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation, and collections from patients and payers.

Featured Articles

Earnings History and Estimates for R1 RCM (NASDAQ:RCM)

Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.